# Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes

> **NCT02409810** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ohio State University** · enrollment: 20 (actual)

## Conditions studied

- Anxiety
- Burns

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT02409810
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2020-03-20
- **Final completion:** 2020-03-20
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02409810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02409810, "Patient-Controlled Anxiolysis With Dexmedetomidine (PCA-DEX) for Burn-care Dressing Changes". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02409810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*